Patent ID: 6300368
Filing Date: 2001-10-09
Classification: C07C,C07D

Abstract:
An anilide derivative represented by formula (1) or a pharmacologically acceptable salt thereof: ##STR14##whereinR.sup.1 represents a phenyl group (except for monoalkoxy phenyl group and monoalkyl phenyl group) having one or two substituents selected from the group consisting of C.sub.1-3 alkoxy groups, C.sub.1-3 alkyl groups, C.sub.1-3 alkanesulfonamido groups and C.sub.1-3 alkanesulfonyl groups; a furyl group; a 2,3,4,5-tetrahydrofuryl group; a 3,4,5,6-tetrahydro-2H-pyranyl group; or --(CH.sub.2).sub.n OR.sup.6 (wherein, n represents an integral number 2 or 3 and R.sup.6 represents a C.sub.1-4 alkyl group), at either the 2-position or both of the 2-position and the 6-position,R.sup.2 and R.sup.3 represent independently a hydrogen atom, a C.sub.1-3 alkoxy group, a C.sub.1-3 alkyl group, or a C.sub.1-3 alkanesulfonamido group, andR.sup.4 and R.sup.5 represent independently a hydrogen atom, a C.sub.1-4 alkyl group, a C.sub.3-6 cycloalkyl group, or --(CH.sub.2).sub.n OR.sup.6 (wherein, n represents an integral number 2 or 3, and R.sup.6 represents a C.sub.1-4 alkyl group).